SCHEMBL5532745

SCHEMBL5532745

CCn1c(COCCSC)nc(C(=O)O)c(OCc2ccccc2)c1=O

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 4/20 0.35
TSHR P16473 2/20 0.35
RXFP1 Q9HBX9 1/20 0.35
MAPK1 P28482 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
ADORA1 P30542 1/20 0.34
ACSS2 Q9NR19 1/20 0.34
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
ATM Q13315 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
KMT2A Q03164 1/20 0.33
PTGES O14684 1/20 0.33
ALOX5 P09917 1/20 0.33
PPARG P37231 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5526219 0.92 ADORA1 (0.34) TSHRRXFP1MAPK1CASP1CASP7
SCHEMBL5534568 0.82 TSHR (0.36) MCL1TSHRRXFP1MAPK1CASP1
SCHEMBL5534178 0.80 TSHR (0.42) TSHRRXFP1MAPK1CASP1CASP7
SCHEMBL5528384 0.77 FPR1 (0.35) TSHRRXFP1MAPK1CASP1CASP7
SCHEMBL4040796 0.71 GRM5 (0.34) MCL1ALDH1A1KMT2A
SCHEMBL4038085 0.69 RNASEH1 (0.41) TSHRMAOBSMN1; SMN2NPC1ALDH1A1
SCHEMBL3420229 0.69 CYP1A2 (0.47) TSHRMAPK1CASP1CASP7MAOA
SCHEMBL2507511 0.69 MAOA (0.48) TSHRMAPK1CASP1CASP7MAOA
SCHEMBL14572114 0.67 KMO (0.39) TSHRMAPK1CASP1CASP7MAOA
SCHEMBL22856950 0.66 TSHR (0.56) TSHRMAPK1SMN1; SMN2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007064316-A1 BICYCLIC HETEROCYCLES AS HIV INTEGRASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-07 WO disclosed
EP-1749011-A1 BICYCLIC HETEROCYCLES AS HIV INTEGRASE INHIBITORS Bristol-Myers Squibb Company (US) 2007-02-07 EP disclosed
WO-2005118593-A1 BICYCLIC HETEROCYCLES AS HIV INTEGRASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-12-15 WO disclosed